Folate Antagonists Flashcards
Folate Antagonists
Trimethoprim/Sulfamethoxazole Dapsone Pyrimethamine Sulfadiazine Sulfadoxine
T/S is most common
Active against bacterial and parasitic/fungal infections
Once was broad spectrum; not now due to resistance; still drug of choice for many infections
Resistance varies by geographical region; consider local angiobiogram before using as empiric therapy
Other agents used for parasitic/fungal infections
This section will refer to T/S except when noted
Folate Antagonists MOA
These drugs inhibit steps in folate biosynthesis pathway- depletes pool of nucleosides- ultimately leads to inhibition of DNA synthesis in susceptible organisms
Folate Antagonists Spectrum
Good Staph aureus (including many MRSA) H. influenzae Stenotrophomonas maltophilia Listeria Pneumocystis jirovecii (formerly P. carinii) Toxoplasma gondii (pyrith and sulfadiaz)
Moderate Enteric GNRs S. pneumo S. pyogenes Salmonella Shigella Nocardia
Poor
Pseudomonas
Enterococci
Anaerobes
Folate Antagonists Adverse Effects
Dermatologic
T/S frequently causes rash (usually because of sulfamethoxazole component)
Rash more common in HIV/AIDS patients
Usually not severe, life threatening reactions can occur (Stevens-Johnson syndrome, toxic epidermal necrolysis)
Hematologic
Dose dependent bone marrow suppression with T/S (especially at higher doses used for Pneumocystis infections)
Renal
T/S can cause true and pseudo renal failure
SMX component can cause crystalluria and AIN leading to acute renal failure
TMP can increase serum creatinine (by blocking its secretion) without a true decline in glomerular filtration rate
TMP can cause hyperkalemia (MOA similar to potassium sparing diuretics like triamterene)
Folate Antagonists Important Facts
T/S was standard first line for acute uncomplicated cystitis in women
In areas with local resistance rates > 15-20% for E. coli, use other drug (like nitrofurantoin); in these cases definitely do not use for empiric therapy of complicated UTIs (pyelonephritis and urosepsis)
T/S comes in a fixed 1:5 ratio Dosing based on TMP component SS- 80:400 DS- 160:800 Excellent oral bioavailability
Significant drug interaction with warfarin- causing higher than anticipated prothrombin times
Avoid with warfarin if possible; if have to use both, then monitor international normalized ratio
Fairly insoluble in IV solutions; large volumes of diluent needed for it to go into solution
Be careful in volume overloaded patients (like heart failure)
Outpatient MRSA strain very susceptible to T/S; like to cause skin infections with abscesses (often large ones); good choice for staph skin infections but must drain abscess
If allergic to T/S, may have cross reactions to other drugs containing sulfonamide moieties (Furosemide, Sulfadiazine, Acetazolamide, HCTZ, Glipizide)
Folate Antagonists Good For
Uncomplicated UTIs (empirically in areas with low local resistance; definitively when susceptible)
Prophylaxis against recurrent UTIs
Treatment Listeria meningitis
Treatment and prophylaxis of P. jirovecii pneumonia
Treatment of Toxoplasma encephalitis
Also alternative therapy for bacterial prostatitis, typhoid fever, MRSA
Sulfadiazine used in treatment of Toxoplasmosis